[Revised practice guideline 'Anaemia in midwifery practice'].

Ned Tijdschr Geneeskd

Koninklijke Nederlandse Organisatie van Verloskundigen, Utrecht, the Netherlands.

Published: March 2012

The practice guideline of the Royal Dutch Organization of Midwives 'Anaemia in primary care midwifery practice' published in 2000, has recently been revised. The revised guideline takes physiological haemodilution during pregnancy into consideration and provides gestation specific reference values for haemoglobin levels. The guideline advises to start iron supplementation only in demonstrated iron deficiency based on low levels of haemoglobin and mean corpuscular volume (MCV). This results in less prescription of iron medications and prescription of lower dosages, which will result in fewer adverse effects and better therapy adherence. New chapters are added concerning anaemia during preconception and the puerperium. More attention is given to women with an increased risk of anaemia in pregnancy and the influence of a positive carrier status for haemoglobinopathy. In order to achieve good continuity of care, collaboration between obstetricians and general practitioners is important.

Download full-text PDF

Source

Publication Analysis

Top Keywords

practice guideline
8
[revised practice
4
guideline
4
guideline 'anaemia
4
'anaemia midwifery
4
midwifery practice']
4
practice'] practice
4
guideline royal
4
royal dutch
4
dutch organization
4

Similar Publications

Introduction: The SAGES Guidelines Committee creates evidence-based clinical practice guidelines (CPGs). Updates which incorporate new evidence into the guidelines are necessary to maintain relevance for clinical use. A description of our standard operating procedure for this process is described here, which contributes to SAGES' commitment to producing high-quality clinical recommendations.

View Article and Find Full Text PDF

Post-Market Evidence for Cancer Medicines in Regulatory and Clinical Decision-Making: A Scoping Review.

Pharmacoepidemiol Drug Saf

January 2025

Charles Perkins Centre and School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Background: Cancer medicines usually have uncertain efficacy and safety profiles when they are first approved by medicines regulators because this evidence usually emerges post-market. Little is known about the extent to which post-market evidence is evaluated and integrated into evidence review processes in regulatory and clinical contexts.

Objectives: The objective of this scoping review is to examine the literature on how post-market evidence on benefits and harms is evaluated and integrated in regulatory decisions and guidance for clinical decision-making.

View Article and Find Full Text PDF

[Recommendations for clinical practice: Prevention and management of varicella zoster virus (VZV) infection during pregnancy and the perinatal period (extended version)].

Gynecol Obstet Fertil Senol

January 2025

Division of Virology, WHO Rubella National Reference Laboratory, Paris Saclay University Hospital, APHP, Paris, France; Université Paris-Saclay, INSERM U1184, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France.

The Société de Pathologie Infectieuse de Langue Française released in 2024 a new national recommendation for clinical practice on the prevention and management of varicella zoster virus (VZV) infection during pregnancy and the perinatal period. The previous recommendation was issued in 1998, at a time of anti-VZV immunoglobulins shortage; it has hence become obsolete. This recommendation is a formalized expert consensus focusing on infectious diseases management; it is drawn up by a multidisciplinary working group (infectiologists, obstetricians, pediatricians, microbiologists, midwives, hygienists).

View Article and Find Full Text PDF

Ramadan intermittent fasting for patients with gastrointestinal and hepatobiliary diseases: practical guidance for health-care professionals.

Lancet Gastroenterol Hepatol

February 2025

Digestive Diseases Unit, Kettering General Hospital, University Hospital of Northamptonshire NHS Group, Kettering, UK; Department of Population Health Sciences, College of Life Sciences, University of Leicester, Leicester, UK.

Ramadan intermittent fasting can pose challenges and risks for some groups of patients. Based on a narrative literature review and our clinical expertise, we provide practical guidance for clinicians managing patients with gastrointestinal and hepatobiliary conditions who wish to fast during Ramadan. Following the established International Diabetes Federation and Diabetes and Ramadan International Alliance risk stratification framework, we categorised patients' risk as low or moderate, high, or very high.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!